Future outlook

Last modified: 31.5.2021

Future outlook

Optomed expects its full year 2021 revenue to grow strongly compared to 2020.(announced 8 April 2021)

 

Previous outlook of 18 February 2021:

Optomed expects its full year 2021 revenue to grow compared to 2020.

Previous outlook of 19 March 2020:

We continue to progress our expansion towards the US and grow our international distributor network. Additionally, we are currently investing in the development of our first fully integrated AI camera with expected commercial launch during 2020.

Optomed expects its revenue to decline during 2020.

The COVID-19 pandemic has a negative effect on Optomed’s growth and business in 2020.

Previous outlook of 28 February 2020:

We continue to progress our expansion towards the US and grow our international distributor network. Additionally, we are currently investing in the development of our first fully integrated AI camera with expected commercial launch during 2020.

Optomed expects its revenue to grow during 2020 and that the growth will focus on the second half of the year.

The COVID-19 Coronavirus outbreak may have a negative impact on the company’s growth affecting both the business in China and the overall business due to the company’s Chinese component suppliers. Further, in case the virus becomes pandemic the company’s global sales could be negatively affected.